Career
| Since 2017 | Head of Chronic Inflammatory Bowel Diseases (IBD) Senior Attending Physician Gastroenterology & Hepatology, USZ |
|---|---|
| 2016 | Habilitation |
| 2012 | Attending Physician Gastroenterology & Hepatology, USZ Specialist title Gastroenterology & Hepatology |
| 2010 | Resident in Gastroenterology & Hepatology, USZ Specialist title in internal medicine |
| 2007 | Resident in Internal Medicine, University Hospital Zurich (USZ) |
| 2005 | Resident at the University Clinic for Internal Medicine, Liestal Cantonal Hospital |
Most important memberships
- FMH (Foederatio Medicorum Helveticorum)
- SGG (Swiss Society of Gastroenterology)
- AGZ (Medical Association of the Canton of Zurich)
- ECCO (European Crohn’s and Colitis Organization)
- AGA (American Gastroenterological Association)
- IBDNet
- EUREOS (European Consortium for Eosinophilic Diseases of the GI Tract)
- ESsCD (European Society for the Study of Coeliac Disease)
- CCS (Crohn’s Colitis Switzerland, Swiss Crohn’s Disease / Ulcerative Colitis Association)
- SGUM (Swiss Society for Ultrasound in Medicine)
- Gastrointestinal League
- SwissNGM (The Neurogastro-Motility Network)
- ESNM (European Society of Neurogastroenterology and Motility)
Research focus
My research focuses on chronic inflammatory bowel disease (IBD) and eosinophilic esophagitis (EoE).
The focus here is on investigations into the epidemiology and natural course of these diseases in connection with current treatment options.
Furthermore, I am investigating the role and influence of environmental factors in combination with other risk factors – such as genetics, intestinal microbiota or psychosocial factors – for these chronic, immune-mediated diseases of the gastrointestinal tract.
The further development of drug, interventional and surgical treatment options is also an important focus. For this reason, numerous novel therapeutic approaches are constantly being researched at the USZ Study Center as part of multicenter studies and can be offered to interested patients.